Feedback / Questions
cizutamig (EMB-06) - Candid Therapeutics
CND261 - Candid Therapeutics
https://www.businesswire.com/news/home/20250619757578/en/Candid-Therapeutics-Advances-Portfolio-of-Novel-T-Cell-Engagers-into-Five-Autoimmune-Diseases-for-Clinical-Evaluation
Jun 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next